What Is TB-500?

Research Notice: This article covers research on TB-500 research peptide and BPC-157 research peptide — available from Palmetto Peptides for laboratory use only.

TB-500 is a synthetic heptapeptide (7 amino acid) fragment of Thymosin Beta-4 (TB4), a naturally occurring 43 amino acid protein involved in actin sequestration and cytoskeletal regulation. TB-500 corresponds specifically to the actin-binding motif of TB4 and has been studied in preclinical models for its roles in cell migration, angiogenesis, and tissue regeneration. Its smaller size relative to full TB4 may confer distinct pharmacokinetic and tissue distribution properties that make it of particular research interest.

Published: March 10, 2026 | Palmetto Peptides Research Team

For research purposes only. Not intended for human or veterinary use. Not for human consumption.

What Does TB-500 Stand For?

TB-500 is the research designation for a specific synthetic fragment of Thymosin Beta-4 (TB4). The parent molecule, TB4, is a 43 amino acid peptide encoded by the TMSB4X gene and one of the most abundant intracellular proteins in mammalian cells. TB-500 isolates the core active sequence — the actin-binding motif, characterized by the LKKTETQ sequence — rather than delivering the full-length protein.

The distinction matters: TB-500 is not the same as Thymosin Beta-4. It is a fragment that retains the functional actin-binding region while being structurally smaller and potentially more accessible to various tissue compartments.

How Is TB-500 Different from Thymosin Beta-4?

TB-500 contains 7 amino acids; Thymosin Beta-4 contains 43. TB-500 isolates the actin-binding motif of TB4, while full-length TB4 includes additional structural regions with potentially different biological activities.

• Full TB4 (43 AA): The complete protein, involved in a broad range of intracellular and extracellular signaling functions including actin sequestration, wound healing, immune regulation, and cardiac tissue repair.
• TB-500 (7 AA): The isolated actin-binding fragment. Research suggests it retains many of TB4's regenerative properties while its smaller molecular size may allow for different biodistribution — potentially reaching tissue compartments that full-length TB4 may not penetrate as readily.

This size-based distribution hypothesis is an active area of research interest and is one reason TB-500 is often studied independently from full TB4.

What Is TB-500 Studied for in Research?

TB-500's primary research interest centers on actin regulation, cytoskeletal remodeling, and the downstream effects on cell migration and tissue repair.

Actin Sequestration

The core function of the TB-500 sequence is binding to G-actin (globular actin) and regulating its availability for polymerization into F-actin (filamentous actin). This sequestration function plays a fundamental role in cell motility, division, and wound response.

Cytoskeletal Remodeling

By modulating actin dynamics, TB-500 influences cytoskeletal architecture in cells involved in repair processes — fibroblasts, endothelial cells, and keratinocytes — the primary cell types involved in wound closure and connective tissue remodeling.

Cell Migration

Enhanced migration of endothelial cells and progenitor cells toward injury sites has been observed in multiple in vitro models, suggesting a potential role in coordinating tissue repair responses.

Angiogenesis

TB-500 has demonstrated pro-angiogenic effects in animal models. The formation of new capillary networks is critical to tissue oxygenation and nutrient delivery during repair, and TB-500 appears to influence this process through endothelial cell activation.

Tissue Regeneration Models

TB-500 has been examined in rodent models of cardiac injury, dermal wounds, corneal damage, and musculoskeletal trauma — with signals consistent with accelerated structural repair across multiple tissue types.

What Is TB-500's Mechanism of Action?

TB-500 works primarily through actin-binding — specifically the sequestration of G-actin — which modulates cytoskeletal dynamics and promotes cell migration and proliferation in preclinical models.

The LKKTETQ motif (Leu-Lys-Lys-Thr-Glu-Thr-Gln) is responsible for its high-affinity binding to G-actin. When actin is sequestered in this way, it shifts the intracellular balance in a manner that promotes dynamic cytoskeletal changes — giving cells the structural flexibility to migrate and reorganize in response to injury signals.

This mechanism is fundamentally different from BPC-157's nitric oxide and GH receptor pathway, which is why the two are often described as mechanistically complementary in multi-compound research designs.

Frequently Asked Questions

Q: Is TB-500 the same as Thymosin Beta-4?
A: No. TB-500 is a 7 amino acid synthetic fragment of Thymosin Beta-4, which is a full 43 amino acid protein. TB-500 isolates the actin-binding motif of TB4 and may have different tissue distribution properties due to its smaller size.

Q: What is the LKKTETQ sequence?
A: LKKTETQ (Leu-Lys-Lys-Thr-Glu-Thr-Gln) is the core actin-binding motif within TB-500. It is responsible for the peptide's high-affinity binding to G-actin, which underlies its cytoskeletal effects in preclinical research.

Q: What tissue types has TB-500 been studied in?
A: Preclinical research has examined TB-500 in cardiac tissue, dermal wounds, corneal tissue, musculoskeletal models, and endothelial cell migration assays.

Q: How is TB-500 different from BPC-157?
A: TB-500 acts through actin-binding and cytoskeletal remodeling; BPC-157 acts through the nitric oxide pathway and GH receptor upregulation. They have different structural origins and distinct mechanisms, though both are studied in tissue repair contexts.

Q: What purity is Palmetto Peptides' TB-500?
A: Palmetto Peptides' TB-500 is COA verified for purity and identity by third-party laboratory testing.

---

Explore Palmetto Peptides Research Compounds

• TB-500 Research Peptide
• BPC-157 + TB-500 Wolverine Stack

All products are research-grade, COA verified, and intended for laboratory research use only.

---